Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Weak
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Neutral
Balance Sheet
Very Weak
Website
N/ATelephone
61.7.3152.3200
Address
Suite 302, Level 3 9 Sherwood Road Toowong Tower Toowong, Queensland (QLD) 4066
Description
Anteris Technologies Ltd. is a structural heart company, which engages in research, develops, commercializes, and distributes medical technologies and devices. It operates through the following geographical segments: Australia, United States, and Switzerland. It manufactures, distributes, and sells ADAPT and DurAVR regenerative tissue products, and researches and develops regenerative medicine and immunotherapies. The company was founded on June 23, 1999 and is headquartered in Toowong, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 7.65 - 23.93
Trade Value (12mth)
AU$60,914.00
1 week
-21.94%
1 month
-31.33%
YTD
-9.04%
1 year
-67.42%
All time high
186.88
EPS 3 yr Growth
67.00%
EBITDA Margin
%
Operating Cashflow
-$51m
Free Cash Flow Return
-234.70%
ROIC
-307.30%
Interest Coverage
-160.10
Quick Ratio
2.50
Shares on Issue (Fully Dilluted)
18m
HALO Sector
Healthcare
Next Company Report Date
26-Feb-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
27 March 25 |
Notification regarding unquoted securities - AVR
×
Notification regarding unquoted securities - AVR |
27 March 25 |
Application for quotation of securities - AVR
×
Application for quotation of securities - AVR |
27 March 25 |
Cleansing Notice
×
Cleansing Notice |
21 March 25 |
Anteris Reports One-Year Patient Outcomes for DurAVR THV
×
Anteris Reports One-Year Patient Outcomes for DurAVR THV |
21 March 25 |
Change of Directors' Interest Notice
×
Change of Directors' Interest Notice |
13 March 25 |
Annual Report to shareholders
×
Annual Report to shareholders |
13 March 25 |
2024 Financial Results and Corporate Update
×
2024 Financial Results and Corporate Update |
13 March 25 |
Corporate Governance Statement and Appendix 4G
×
Corporate Governance Statement and Appendix 4G |
11 March 25 |
Cleansing Notice
×
Cleansing Notice |
07 March 25 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
06 March 25 |
Director Appointment/Resignation
×
Director Appointment/Resignation |
05 March 25 |
Application for quotation of securities - AVR
×
Application for quotation of securities - AVR |
05 March 25 |
Statement of CDIs on issue - AVR
×
Statement of CDIs on issue - AVR |
28 February 25 |
ASX waiver from requirement to lodge an Appendix 4E
×
ASX waiver from requirement to lodge an Appendix 4E |
18 February 25 |
Notification of cessation of securities - AVR
×
Notification of cessation of securities - AVR |
13 February 25 |
Release of Australian Taxation Office Class Rulings
×
Release of Australian Taxation Office Class Rulings |
12 February 25 |
Application for quotation of securities - AVR
×
Application for quotation of securities - AVR |
03 February 25 |
Statement of CDIs on issue - AVR
×
Statement of CDIs on issue - AVR |
16 January 25 |
Cleansing Notice
×
Cleansing Notice |
15 January 25 |
Partial Exercise of Option and End of Stabilisation Period
×
Partial Exercise of Option and End of Stabilisation Period |
13 January 25 |
Daily Stabilisation Activity Report - 10 January 2025
×
Daily Stabilisation Activity Report - 10 January 2025 |
09 January 25 |
Daily Stabilisation Activity Report - 8 January 2025
×
Daily Stabilisation Activity Report - 8 January 2025 |
08 January 25 |
Daily Stabilisation Activity Report - 7 January 2025
×
Daily Stabilisation Activity Report - 7 January 2025 |
08 January 25 |
Statement of CDIs on issue - AVR
×
Statement of CDIs on issue - AVR |
07 January 25 |
Daily Stabilisation Activity Report - 6 January 2025
×
Daily Stabilisation Activity Report - 6 January 2025 |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.